Walk through the supplement aisle of any pharmacy and you’ll find shelf after shelf of promises — stronger bones, sharper memory, less joint pain, better sleep. Americans spend roughly $60 billion a year on dietary supplements, and seniors are among the most enthusiastic buyers. But which of these products actually deliver, which are harmless but ineffective, and which could do real damage? The answers are more nuanced than the marketing suggests.
Older adults are often drawn to supplements because aging changes appetite, digestion, medication use, and nutrient absorption. But the general rule is simple: supplements work best when they fill a documented gap, and they are least useful when they are taken as a broad “insurance policy” by otherwise well-nourished people. Let’s take a closer look.
First, a ground rule that applies to everything in this article: dietary supplements are not FDA-approved drugs. The FDA treats them more like foods, meaning manufacturers don’t have to prove effectiveness before selling them. Quality control also varies widely — what’s on the label may not always match what’s in the bottle. As a result, the scientific evidence behind many supplements is limited or inconsistent. When shopping, look for products with a USP (United States Pharmacopeia) verified mark, which indicates independent testing for identity, purity, and potency.
The Genuinely Helpful Ones
Vitamin D and Calcium are probably the most well-supported supplements for older adults. Bone loss accelerates with age, and these two nutrients work as a team — calcium provides the raw material for bone, while vitamin D helps the body absorb it. The National Institute on Aging recommends 600 IU of vitamin D daily for adults aged 51–70, and 800 IU for those over 70. Most seniors don’t get enough from diet or sun exposure alone, making supplementation genuinely sensible for many people. This is especially true for prople with documented deficiency or osteoporosis risk. One important caveat: don’t go overboard. Too much vitamin D can cause calcium to build up in the blood, potentially harming the kidneys and blood vessels.
Vitamin B12 is another legitimate priority; Up to 15 percent of older adults may bedeficient.. Older adults are prone to B12 deficiency not because they eat less of it, but because the stomach produces less acid with age, and stomach acid is needed to release B12 from food. Those taking acid-blocking medications are at even higher risk. Deficiency can cause nerve damage and anemia. The good news is that the form of B12 in supplements is absorbed without needing stomach acid, making supplements effective where food sources may fall short.
Omega-3 fatty acids, found in fish oil, have earned a solid reputation for lowering triglycerides — a type of blood fat linked to heart disease. A large study of over 400,000 people found associations between fish oil use and improved cholesterol profiles. However, the picture is more complicated for other claimed benefits. Evidence for omega-3s preventing dementia is mixed, and some research suggests fish oil can actually raise LDL (“bad”) cholesterol in certain people, so monitoring is wise. For those who can’t eat fatty fish regularly, fish oil is a reasonable backup — just don’t expect miracles beyond the triglyceride benefit.
Melatonin has moderate scientific support for improving sleep, which is a chronic issue for many older adults. It’s particularly helpful for resetting disrupted sleep cycles. The key is using it at low doses — often 0.5 to 3 mg is sufficient, though most over-the-counter products contain far more. It’s generally well tolerated but should not replace evaluation of underlying sleep disorders.
Creatine and protein supplements may sound like something only gym rats need, but research increasingly supports their role in combating sarcopenia — the age-related loss of muscle mass that can lead to falls and loss of independence. A 2024 Stanford review found that creatine supplementation, combined with resistance training, can meaningfully preserve muscle in adults over 65. Branched-chain amino acids (BCAAs) can play a supporting role in certain situations, particularly when protein intake from food is inadequate. Vegans should pay particular attention to protein intake.
The Ambiguous Middle Ground
Glucosamine and chondroitin are among the most popular supplements for joint pain, and the scientific debate around them has been going on for decades. These are naturally occurring compounds in cartilage, and the theory is that supplementing them may slow joint deterioration in osteoarthritis. A 2024 systematic review of 146 studies found that over 90% of the studies reported positive outcomes — impressive on its face. But the landmark NIH-funded GAIT trial told a more sobering story: glucosamine and chondroitin, alone or together, were no more effective than a placebo for most people with knee osteoarthritis. The exception was a subgroup with moderate-to-severe pain, who did show moderate improvement. Safety is generally good, but those on blood thinners like warfarin should be careful, as glucosamine may affect clotting.
Turmeric and curcumin have generated enormous popular interest, and there’s at least a plausible scientific basis for the excitement. Curcumin, the active compound in turmeric, is a potent anti-inflammatory and antioxidant. Multiple clinical trials support some benefit for knee pain, and some research suggests potential benefits for cognitive health. However, curcumin is poorly absorbed on its own, which is why many products add black pepper (piperine) or use enhanced delivery formulations. The overall evidence, while promising, is still described as “mixed or low quality” by most reviewers. If you do try it, look for a formulation with enhanced bioavailability and give it at least 4–8 weeks and be aware that it may cause gastrointestinal symptoms.
Saw palmetto is widely used by older men for symptoms of benign prostatic hyperplasia (BPH) — the enlarged prostate that causes frequent urination. A 2024 updated Cochrane review found some evidence of limited benefit for urinary symptoms for some men, though the results are inconsistent and most mainstream urology guidelines do not formally recommend it. It’s generally well tolerated. Men using it should still get their prostate checked regularly and not assume saw palmetto rules out other conditions.
Magnesium has had a social media moment, with enthusiastic claims about better sleep, improved mood, and reduced muscle cramps. The actual science is more cautious — there’s limited evidence for magnesium supplements providing any of these benefits in people who aren’t already deficient. That said, deficiency is relatively common in older adults, and correction of a true deficiency can absolutely help. A blood test can tell you if you actually need it.
Multivitamins present a genuine paradox. They’re the most commonly taken supplement category, often recommended by physicians as a nutritional safety net. And for seniors with reduced appetite or limited dietary variety, that logic holds. But large, well-designed studies have found limited evidence that multivitamins improve longevity or prevent major diseases in otherwise healthy older adults. A newer 2024 analysis from the COSMOS trial suggests some modest benefit for cognitive function. Senior-specific multivitamins are preferred — they typically contain more vitamin D and B12 and less or no iron, which reflects the actual needs of older adults.
The Ones That Raise Red Flags
Iron supplements deserve special caution in older men and post-menopausal women. Unless there’s a documented deficiency confirmed by blood testing, taking iron supplements can be harmful. In men, iron overload is a genuine risk, and about twice as many men carry the gene for hereditary hemochromatosis (a condition where the body absorbs too much iron) as carry the gene for iron deficiency. Excess iron has been linked to liver damage and may raise cancer risk. Senior-specific multivitamins wisely contain little or no iron for exactly this reason.
High-dose Vitamin A is another potential problem. The liver’s ability to clear vitamin A decreases with age, and older adults absorb more of it. Doses above recommended daily values can accumulate to toxic levels, potentially harming the liver. This is specifically the retinol form of vitamin A. Beta-carotene from plant sources is much safer. Check your multivitamin label carefully.
High dose Vitamin B6 can cause nerve damage, balance problems, and sensory neuropathy when taken over long periods but is safe at recommended levels.
Many supplements claim to improve memory or prevent dementia. Unfortunately, the evidence is generally weak. Fish oil, ginkgo biloba, and other popular products have not demonstrated clear benefits for preventing cognitive decline in controlled studies. Some research suggests that long-term supplementation with B vitamins might slow certain aspects of cognitive decline in specific populations, but results remain inconsistent.
St. John’s Wort is widely used for mild depression, but it comes with a serious warning: it interacts with a long list of medications, including antidepressants, blood thinners, heart medications, and antiretroviral drugs. For seniors managing multiple conditions with multiple prescriptions, this herb is particularly risky. Ginkgo biloba carries similar drug interaction concerns, especially around bleeding risk when combined with blood thinners or aspirin.
High-dose antioxidants — vitamins A, C, and E taken in large amounts — have largely failed to deliver on their promise of preventing heart disease and cancer. The US Preventive Services Task Force does not recommend these for prevention. In some cases, large antioxidant supplements may actually interfere with the body’s natural disease-fighting mechanisms.
The Bottom Line
Given the mixed evidence, a sensible approach to supplements includes several principles:
- Food first. A balanced diet usually provides most necessary nutrients.
- Test before supplementing. Blood tests can identify deficiencies such as B12 or Vitamin D.
- Avoid megadoses. Excessive intake of vitamins can cause toxicity.
- Check medication interactions. Many supplements interact with common drugs, including blood thinners.
- Treat supplements like medications. They should have a clear purpose and measurable benefit.
Supplements that address documented deficiencies or fill genuine dietary gaps — vitamin D, B12, calcium, omega-3s — offer the best evidence for benefit in seniors. Joint supplements like glucosamine and turmeric may help some people, though the evidence is mixed enough that a try-and-see approach (with a 2–3 month window to assess benefit) is reasonable. And several common supplements, particularly iron in unsupervised use, high-dose vitamin A, and certain herbals in combination with medications, carry risks that are easy to overlook because they’re sold without a prescription.
I always advised my patients to bring all their supplement bottles to at least one visit each year and to bring any medicines prescribed by specialists. Physicians can spot dangerous overlaps, flag interactions with your prescriptions, and tell you if what you’re taking makes sense for you. Many seniors never hear a list of side effects for supplements the way they do for prescription drugs — and they often assume that means there aren’t any. That assumption, unfortunately, can be costly.
Illustration generated by author using ChatGPT.
Sources
National Institute on Aging. Dietary Supplements for Older Adults.
National Institute on Aging. Vitamins and Minerals for Older Adults.
Linus Pauling Institute, Oregon State University. Older Adults — Micronutrient Information Center.
National Center for Health Research. Glucosamine Supplements: Do They Work and Are They Safe?
BodySpec. Supplements for Joint Health: 2025 Evidence-Based Guide.
Cleveland Clinic. Dietary Supplements Compound Health Issues for Older Adults.
FDA. Mixing Medications and Dietary Supplements Can Endanger Your Health.
NIH Office of Dietary Supplements. Iron — Health Professional Fact Sheet.
Foods (MDPI). Food Supplements and Their Use in Elderly Subjects — Challenges and Risks. 2024.
Memorial Healthcare System. Herbal Supplements and Prescription Drugs: Know the Risks. 2024.
WebMD. Saw Palmetto: Overview, Uses, Side Effects, Precautions.
________________________________________________
Medical Disclaimer
The information provided in this article is intended for general educational and informational purposes only and does not constitute medical advice. It should not be used as a substitute for professional medical advice, diagnosis, or treatment.
Always seek the guidance of a qualified healthcare provider with any questions you may have regarding a medical condition or treatment. Never disregard professional medical advice or delay seeking it because of something you have read here.
If you are experiencing a medical emergency, call 911 or your local emergency number immediately.
The author of this article is a licensed physician, but the views expressed here are solely those of the author and do not represent the official position of any hospital, health system, or medical organization with which the author may be affiliated.
America’s Healthcare Paradox: Why We Pay Double and Get Less
By John Turley
On January 5, 2026
In Commentary, Medicine
The healthcare debate in America often circles back to a fundamental question: should we move toward a single-payer system, or is our current mixed public-private model the better path forward? It’s a conversation that gets heated quickly, but when you strip away the politics and look at how different systems actually function around the world, some interesting patterns emerge.
What We Mean by Single-Payer
A single-payer healthcare system means that one entity—usually the government or a government-related organization—pays for all covered healthcare services. Doctors and hospitals can still be private (and usually are), but instead of dealing with dozens of different insurance companies, they bill one source. It’s a lot like Medicare, which is why proponents often call it “Medicare-for-all”.
The key thing to understand is that single-payer isn’t necessarily the same as socialized medicine. In Canada’s system, for instance, the government pays the bills, but doctors are largely in the private sector and hospitals are controlled by private boards or regional health authorities rather than being part of the national government. Compare that to the UK’s National Health Service, where many hospitals and clinics are government-owned and many doctors are government employees.
America’s Current Patchwork
The United States operates what might charitably be called a “creative” approach to healthcare—a complex mix of employer-sponsored private insurance, government programs like Medicare, Medicaid and the VA system, individual marketplace plans, and direct out-of-pocket payments. Government already pays roughly half of total US health spending, but benefits, cost-sharing, and networks vary widely between plans, with little overall coordination. In 2023, private health insurance spending accounted for 30 percent of total national health expenditures, Medicare covered 21 percent, and Medicaid covered 18 percent. Most of the remainder was either paid out of pocket by private citizens or was written off by providers as uncollectible.
Here’s where it gets expensive. U.S. health care spending grew 7.5 percent in 2023, reaching $4.9 trillion or $14,570 per person, accounting for 17.6 percent of the nation’s GDP, and national health spending for 2024 is expected to have exceeded $5.3 trillion or 18% of GDP, and health spending is expected to grow to 20.3 percent of GDP by 2033.
For a typical American family, the costs are real and rising. In 2024, the estimated cost of healthcare for a family of four in an employer-sponsored health plan was $32,066.
The European Landscape
Europe doesn’t have one healthcare model—it has several, and they’re all quite different from what we have in the States. Most of the 35 countries in the European Union have single-payer healthcare systems, but the details vary considerably.
Countries like the UK, Sweden, and Norway operate what are essentially single-payer systems where it is solely the government who pays for and provides healthcare services and directly owns most facilities and employs most clinical and related staff with funds from tax contributions. Then you have countries like Germany, and Belgium that use “sickness funds”—these are non-profit funds that don’t market, cherry pick patients, set premiums or rates paid to providers, determine benefits, earn profits or have investors. They’re quasi-public institutions, not private insurance companies like we know them in America. Some systems, such as the Netherlands or Switzerland, rely on mandatory individually purchased private insurance with tight regulation and subsidies, achieving universal coverage with a structured, competitive market.
The French System
France is particularly noted for a successful universal, government-run health insurance system usually described as a single-payer with supplements. All legal residents are automatically covered through the national health insurance program, which is funded by payroll taxes and general taxation.
Most physicians and hospitals are private or nonprofit, not government employees or facilities. Patients generally have free choice of doctors and specialists, though coordinating through a primary care physician improves access and reimbursement. The national insurer pays a large portion of medical costs (often 70–80%), while voluntary private supplemental insurance covers most remaining out-of-pocket expenses such as copays and deductibles.
France is known for spending significantly less per capita than the United States. Cost controls come from nationally negotiated fee schedules and drug pricing rather than limits on access.
What’s striking is that in 2019, US healthcare spending reached $11,072 per person—over double the average of $5,505 across wealthy European nations. Yet despite spending roughly twice as much per person, American health outcomes often lag behind.
The Outcomes Question
This is where the comparison gets uncomfortable for American exceptionalism. The U.S. has the lowest life expectancy at birth among comparable wealthy nations, the highest death rates for avoidable or treatable conditions, and the highest maternal and infant mortality.
In 2023, life expectancy in comparable countries was 82.5 years, which is 4.1 years longer than in the U.S. Japan manages this with healthcare spending at just $5,300 per capita, while Americans spend more than double that amount.
Now, it’s important to note that healthcare systems don’t operate in a vacuum. Life expectancy is influenced by many factors beyond medical care—diet, exercise, smoking, gun violence, drug overdoses, and social determinants of health all play roles. But when you’re spending twice as much and getting worse results, it suggests the system itself might be part of the problem.
Advantages of Single-Payer Systems
The case for single-payer rests on several compelling points. First, administrative simplicity translates to real cost savings. A study found that the administrative burden of health care in the United States was 27 percent of all national health expenditures, with the excess administrative cost of the private insurer system estimated at about $471 billion in 2012 compared to a single-payer system like Canada’s. That’s over $1 out of every $5 of total healthcare spending just going to paperwork, billing disputes, and insurance company profit and overhead before any patient receives care.
Universal coverage is another major advantage. In a properly functioning single-payer system, nobody goes bankrupt from medical bills, nobody delays care because they can’t afford it, and nobody loses coverage when they lose their job. The peace of mind that comes with knowing you’re covered regardless of employment status or pre-existing conditions is difficult to quantify but enormously valuable.
Single-payer systems also have significant negotiating power. When one entity is buying drugs and services for an entire nation, pharmaceutical companies and medical device manufacturers have much less leverage to charge whatever they want. This helps explain why prescription drug prices in other countries are often a fraction of prices in the U.S.
Disadvantages and Trade-offs
The critics of single-payer systems aren’t wrong about everything. Wait times are a genuine concern in some systems. When prices and overall budgets are tightly controlled, some countries experience longer waits for selected elective surgeries, imaging, or specialty visits, especially if investment lags demand.
In 2024, Canadian patients experienced a median wait time of 30 weeks between specialty referral and first treatment, up from 27.2 weeks in 2023, with rural areas facing even longer delays. For procedures like elective orthopedic surgery, patients wait an average of 39 weeks in Canada.
However, it’s crucial to understand that wait times are not a result of the single-payer system itself but of system management, as wait times vary significantly across different single-payer and social insurance systems. Many European countries with universal coverage don’t experience the same wait time issues that plague Canada.
The transition costs are also substantial. Moving from our current system to single-payer would disrupt a massive industry. Over fifteen percent of our economy is related to health care, with half spent by the private sector. Around 160 million Americans currently have insurance through their employers, and transitioning all of them to a government-run plan would be an enormous administrative and political challenge.
A large national payer can be slower to change benefit designs or adopt new payment models; shifting political majorities can affect funding levels and benefit generosity.
Taxes would need to increase significantly to fund such a system, though proponents argue this would be offset by the elimination of insurance premiums, deductibles, and co-pays. It’s essentially a question of whether you’d rather pay through taxes or through premiums—the money has to come from somewhere.
Advantages of America’s Mixed System
Our current system does have some genuine strengths. Innovation thrives in the American healthcare market. The profit motive, for all its flaws, does drive pharmaceutical research and medical device development. American medical schools and research institutions lead the world in many areas of medicine. Academic medical centers and specialty hospitals deliver advanced procedures and complex care that attract patients internationally.
The system also offers more choice for those who can afford it. If you have good insurance, you typically face shorter wait times for elective procedures and can often see specialists without lengthy delays. Americans with high-quality employer-sponsored coverage give their plans relatively high ratings.
Competition between providers can theoretically drive quality improvements, though this effect is often undermined by the complexity of the market and the difficulty consumers face in shopping for healthcare.
Disadvantages of the Current U.S. System
The most glaring problem is simple: The United States remains the only developed country without universal healthcare, and 30 million Americans remain uninsured despite gains under the Affordable Care Act, and many of these gains will soon be lost. Being uninsured in America isn’t just an inconvenience—it can be deadly. People delay care, skip medications, and avoid preventive screenings because of cost concerns.
The administrative complexity is staggering. Doctors spend enormous amounts of time dealing with insurance companies, prior authorizations, and billing disputes. Hospitals employ armies of billing specialists just to navigate the maze of different insurance plans, each with its own rules, formularies, and coverage determinations. U.S. administrative costs account for ~25% of all healthcare spending, among the highest in the world.
Medical bankruptcy is uniquely American. Even people with insurance can find themselves financially devastated by serious illness. High deductibles, surprise bills, and out-of-network charges create a minefield of potential financial catastrophe. Studies of U.S. bankruptcy filings over the past two decades have consistently found that medical bills and medical problems are a major factor in a large share of consumer bankruptcies. Recent summaries suggest that roughly two‑thirds of US personal bankruptcies involve medical expenses or illness-related income loss, and around 17% of adults with health care debt report declaring bankruptcy or losing a home because of that debt.
The system is also profoundly inequitable. Quality of care often depends more on your job, your income, and your zip code than on your medical needs. Out-of-pocket costs per capita have increased as compared to previous decades and the burden falls disproportionately on those least able to afford it.
What Europe Shows Us
The European experience demonstrates that there isn’t one “right” way to achieve universal coverage. The UK’s NHS, Germany’s sickness funds, and France’s hybrid system all manage to cover everyone at roughly half the per-capita cost of American healthcare. Universal Health Coverage exists in all European countries, with healthcare financing almost universally government managed, either directly through taxation or semi-directly through mandated and government-subsidized social health insurance.
They’ve accomplished this through various combinations of centralized negotiation of drug prices, global budgets for hospitals, strong primary care systems that serve as gatekeepers to more expensive specialist care, emphasis on preventive services, and regulation that prevents insurance companies from cherry-picking healthy patients.
Are these systems perfect? No. One of the major disadvantages of centralized healthcare systems is long wait lists to access non-urgent care, though Americans often wait as long or longer for routine primary care appointments as do patients in most universal-coverage countries. Many European countries are wrestling with funding challenges as populations age and expensive new treatments become available. But they’ve solved the fundamental problem that America hasn’t: they ensure everyone has access to healthcare without the risk of financial ruin.
The Path Forward?
The debate over healthcare in America often presents false choices. We don’t have to choose between Canadian-style single-payer and our current system—there are multiple models we could adapt. We could move toward a German-style system with heavily regulated non-profit insurers. We could create a robust public option that competes with private insurance. We could expand Medicare gradually by lowering the eligibility age over time.
What’s clear from international comparisons is that the status quo is unusually expensive and produces mediocre results. We’re paying premium prices for economy outcomes. Whether single-payer is the answer depends partly on your priorities. Do you value universal coverage and cost control more than unlimited choice? Are you willing to accept potentially longer wait times for non-urgent care in exchange for lower costs and universal access? How much do you trust government to manage a program this large?
These aren’t easy questions, and reasonable people disagree. But the evidence from Europe suggests that universal coverage at reasonable cost is achievable—it just requires us to make some choices about what we value most in a healthcare system.
Sources: